ijms-logo

Journal Browser

Journal Browser

Lipopolysaccharide in the Health and Disease

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Biochemistry".

Deadline for manuscript submissions: 20 September 2024 | Viewed by 88

Special Issue Editors


E-Mail Website
Guest Editor
Control of Innate Immunity Collaborative Research Association, FROM KAGAWA 3F, Bio laboratory, 2217-16, Hyashi-cho Takamatsu-shi, Kagawa 761-0301, Japan
Interests: LPS; function of tissue macrophages; mode of action of oral administration of LPS; cognitive dysfunction; reverse aging
Special Issues, Collections and Topics in MDPI journals

E-Mail
Guest Editor
Control of Innate Immunity Collaborative Research Association, FROM KAGAWA 3F, Bio laboratory, 2217-16, Hyashi-cho Takamatsu-shi, Kagawa 761-0301, Japan
Interests: health maintenance by innate immunity; removal of senescent cells by macrophages; food-derived LPS; LPS effects on the host in intestinal bacteria and indigenous skin bacteria

Special Issue Information

Dear Colleagues,

LPS has potent immune-activating effects. Therefore, LPS has been widely used in research as a substance that easily induces inflammation, but the physiological role that LPS originally plays has not received much attention. However, LPS is ubiquitous in the environment and in the digestive tract. Therefore, the mucous membranes and skin of living individuals are permanently exposed to LPS. In other words, LPS is not toxic when administered to mucous membranes or skin. In fact, the oral administration of LPS has been shown to improve lifestyle-related diseases and lipid disorders, reduce the side-effects of anticancer drugs, improve cognitive functions, alleviate allergic symptoms, and prevent viral infections, without inducing inflammation, completely different from cases where LPS is administered intravascularly.

We hope to receive submissions about new discoveries related to the usefulness of LPS. On the other hand, papers that view LPS as merely a disease-aggravating factor or that focus solely on its inflammation-inducing effects are discouraged.

Dr. Gen-Ichiro Soma
Dr. Hiroyuki Inagawa
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • usefulness of LPS
  • oral and/or dermal administration of LPS
  • lifestyle disease
  • cognitive dysfunction
  • allergy
  • autoimmune disorder
  • wound healing
  • cancer

Published Papers

This special issue is now open for submission.
Back to TopTop